Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

BRCA1 and friends 30 years on

Nature Reviews Genetics volume 25, pages 671–672 (2024)Cite this article

Subjects

With the benefit of hindsight, recognition of the cancer susceptibility gene BRCA1 and its later cloning were defining moments for breast and ovarian cancer genetics that should be celebrated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).

    Article  CAS  PubMed  Google Scholar 

  2. Hall, J. M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).

    Article  CAS  PubMed  Google Scholar 

  3. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792 (1995).

    Article  CAS  PubMed  Google Scholar 

  4. Moslehi, R. et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am. J. Hum.Genet. 66, 1259–1272 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J. Am. Med. Assoc. 317, 2402–2416 (2017).

    Article  CAS  Google Scholar 

  6. Foulkes, W. D. The ten genes for breast (and ovarian) cancer susceptibility. Nat. Rev. Clin. Oncol. 18, 259–260 (2021).

    Article  CAS  PubMed  Google Scholar 

  7. Pharoah, P. D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33–36 (2002).

    Article  CAS  PubMed  Google Scholar 

  8. Tutt, A. N. J. et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N. Engl. J. Med. 384, 2394–2405 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Manickam, K. et al. Exome sequencing-based screening for BRCA1/2 expected pathogenic variants among adult biobank participants. JAMA Netw. Open 1, e182140 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hughley, R. et al. Etiologic index - a case-only measure of BRCA1/2-associated cancer risk. N. Engl. J. Med. 383, 286–288 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Genetics, McGill University, Montreal, Quebec, Canada

    William D. Foulkes

Authors
  1. William D. Foulkes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William D. Foulkes.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Related links

All of Us: https://allofus.nih.gov/

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Foulkes, W.D. BRCA1 and friends 30 years on. Nat Rev Genet 25, 671–672 (2024). https://doi.org/10.1038/s41576-024-00754-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41576-024-00754-6

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer